COSCIENS Biopharma Inc. Number Of Share Options Exercised In Share-based Payment Arrangement
COSCIENS Biopharma Inc. (CSCIF) reported Number Of Share Options Exercised In Share-based Payment Arrangement of 1.42 thousand shares for the 12-month period ending 2023-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2026-03-25
- 2019-09-30: Number Of Share Options Exercised In Share-based Payment Arrangement 1 month 37.10K Employee; Number Of Share Options Exercised In Share-based Payment Arrangement 9 month 37.10K Employee.
Employee
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement 1 month | Number Of Share Options Exercised In Share-based Payment Arrangement 9 month |
|---|---|---|
| 2019-09-30 | 37.10K Employee 20-F · filed 2020-03-31 | 37.10K Employee 6-K · filed 2019-11-07 |
Period
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement 3 month |
|---|---|
| 2021-03-31 | 34.89M Period 6-K · filed 2021-05-05 |
shares
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement 1 month | Number Of Share Options Exercised In Share-based Payment Arrangement 3 month | Number Of Share Options Exercised In Share-based Payment Arrangement 6 month | Number Of Share Options Exercised In Share-based Payment Arrangement 9 month | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | 0.00 shares derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | 944.00 shares derived: sum of 2 quarters · filed 2026-03-25 | 1.42K shares 20-F · filed 2026-03-25 | ||
| 2023-09-30 | 944.00 shares derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | 1.42K shares 6-K · filed 2024-11-12 | |||
| 2023-06-30 | 472.00 shares 6-K · filed 2024-08-13 | ||||
| 2022-12-31 | -1.39M shares derived: 20-F 12 month − 6-K 9 month · filed 2025-04-09 | 12.92K shares 20-F · filed 2025-04-09 | |||
| 2022-09-30 | 1.40M shares 6-K · filed 2022-11-03 | ||||
| 2021-12-31 | 100.00K shares derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | 33.71M shares derived: sum of 2 quarters · filed 2022-03-29 | 222.22K shares derived: sum of 3 quarters · filed 2022-08-04 | 35.11M shares 20-F · filed 2022-03-29 | |
| 2021-09-30 | 33.61M shares derived: 6-K 9 month − 6-K/A 6 month · filed 2021-11-04 | 122.22K shares derived: sum of 2 quarters · filed 2022-08-04 | 35.01M shares 6-K · filed 2021-11-04 | ||
| 2021-06-30 | -33.48M shares derived: 6-K/A 6 month − 6-K 3 month · filed 2022-08-04 | 1.40M shares 6-K/A · filed 2022-08-04 | |||
| 2021-03-31 | 34.89M shares 6-K · filed 2022-05-11 | ||||
| 2019-09-30 | 37.10K shares 40-F/A · filed 2021-03-29 |